Ironwood Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IRWD Nasdaq 2836 ironwoodpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ironwood Pharmaceuticals, Inc.

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Jan 8th, 2026 7:36 am
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating - Jan 7th, 2026 1:25 pm
5 Small Drug Stocks to Buy as Industry Recovery Picks Up - Jan 7th, 2026 6:45 am
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026 - Jan 5th, 2026 8:28 am
Ironwood backs FY25 revenue view $290M-$310M, consensus $306.97M - Jan 3rd, 2026 5:20 am
Ironwood sees FY26 revenue $450M-$475M, consensus $319.47M - Jan 3rd, 2026 5:20 am
Dow, S&P 500 Close Higher on First Trading Day of 2026; Major Indexes Post Weekly Losses - Jan 2nd, 2026 2:59 pm
Sector Update: Health Care Stocks Advance Late Afternoon - Jan 2nd, 2026 1:53 pm
Equity Markets Mixed Intraday as 2026 Trading Begins; Tesla Drops - Jan 2nd, 2026 12:30 pm
Ironwood Pharmaceuticals Stock Soars as Drug-Price Cut Boosts Prospects for 2026 - Jan 2nd, 2026 10:21 am
BC-Most Active Stocks - Jan 2nd, 2026 8:30 am
Ironwood Pharmaceuticals Projects Higher 2026 US Sales for Irritable Bowel Syndrome With Constipation Drug - Jan 2nd, 2026 7:27 am
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance - Jan 2nd, 2026 5:05 am
Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report? - Dec 10th, 2025 9:30 am
What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? - Nov 29th, 2025 3:08 pm
Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations - Nov 28th, 2025 8:11 am
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? - Nov 27th, 2025 9:58 am
Short Bowel Syndrome Market to Register Stunning Growth at a CAGR of 5% During the Forecast Period (2025-2034) Owing to the Launch of Novel GLP-2 Analogues | DelveInsight - Nov 24th, 2025 3:31 pm
Ironwood Pharmaceuticals (IRWD): Assessing Valuation Following Q3 Earnings Beat, Guidance Raise, and FDA Approval - Nov 13th, 2025 10:14 am
New Forecasts: Here's What Analysts Think The Future Holds For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Nov 12th, 2025 4:25 am